TY - JOUR
T1 - Results of catheter ablation of typical atrial flutter
AU - Calkins, Hugh
AU - Canby, Robert
AU - Weiss, Raul
AU - Taylor, Gregg
AU - Wells, Peter
AU - Chinitz, Larry
AU - Milstein, Simon
AU - Compton, Steven
AU - Oleson, Kimberly
AU - Sherfesee, Lou
AU - Onufer, John
N1 - Funding Information:
This study was supported by Medtronic EP Systems, Minneapolis, Minnesota.
PY - 2004/8/15
Y1 - 2004/8/15
N2 - The purpose of this study was to evaluate the safety and efficacy of radiofrequency (RF) ablation of typical atrial flutter by using an 8-mm electrode catheter and a 100-W RF power generator. A limitation of previous trials of catheter ablation of atrial flutter is that the data were not collected as part of a prospective multicenter clinical trial. The study results associated catheter ablation of typical atrial flutter in a cohort of 150 patients with an 88% acute efficacy rate. At 6-month follow-up, recurrent typical atrial flutter was observed in 13% of patients. Of the 12 patients with typical atrial flutter recurrence, 4 were symptomatic and 8 were asymptomatic. Procedure duration was a significant predictor of typical atrial flutter recurrence. The 12-month rate for development of atrial fibrillation was 30%. Catheter ablation of atrial flutter was associated with significant improvements in 5 of 8 domains of the Short Form 36 Survey (quality of life) and significant decreases in 13 of the 16 symptoms of the Symptom Checklist. The device- or procedure-related complication rate was 2.7%. Skin burns occurred at the dispersive pad site due to stronger RF power in 3 patients. Use of a dual dispersive pad system mitigated this problem. Thus, the results of this study associated catheter ablation of atrial flutter with high acute efficacy, a small risk of recurrent atrial flutter, and an important risk of atrial fibrillation during follow-up.
AB - The purpose of this study was to evaluate the safety and efficacy of radiofrequency (RF) ablation of typical atrial flutter by using an 8-mm electrode catheter and a 100-W RF power generator. A limitation of previous trials of catheter ablation of atrial flutter is that the data were not collected as part of a prospective multicenter clinical trial. The study results associated catheter ablation of typical atrial flutter in a cohort of 150 patients with an 88% acute efficacy rate. At 6-month follow-up, recurrent typical atrial flutter was observed in 13% of patients. Of the 12 patients with typical atrial flutter recurrence, 4 were symptomatic and 8 were asymptomatic. Procedure duration was a significant predictor of typical atrial flutter recurrence. The 12-month rate for development of atrial fibrillation was 30%. Catheter ablation of atrial flutter was associated with significant improvements in 5 of 8 domains of the Short Form 36 Survey (quality of life) and significant decreases in 13 of the 16 symptoms of the Symptom Checklist. The device- or procedure-related complication rate was 2.7%. Skin burns occurred at the dispersive pad site due to stronger RF power in 3 patients. Use of a dual dispersive pad system mitigated this problem. Thus, the results of this study associated catheter ablation of atrial flutter with high acute efficacy, a small risk of recurrent atrial flutter, and an important risk of atrial fibrillation during follow-up.
UR - http://www.scopus.com/inward/record.url?scp=4344645991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4344645991&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2004.04.058
DO - 10.1016/j.amjcard.2004.04.058
M3 - Article
C2 - 15325925
AN - SCOPUS:4344645991
SN - 0002-9149
VL - 94
SP - 437
EP - 442
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 4
ER -